A proteomic approach to obesity and type 2 diabetes

The incidence of obesity and type diabetes 2 has increased dramatically resulting in an increased interest in its biomedical relevance. However, the mechanisms that trigger the development of diabetes type 2 in obese patients remain largely unknown. Scientific, clinical and pharmaceutical communities are dedicating vast resources to unravel this issue by applying different omics tools. During the last decade, the advances in proteomic approaches and the Human Proteome Organization have opened and are opening a new door that may be helpful in the identification of patients at risk and to improve current therapies. Here, we briefly review some of the advances in our understanding of type 2 diabetes that have occurred through the application of proteomics. We also review, in detail, the current improvements in proteomic methodologies and new strategies that could be employed to further advance our understanding of this pathology. By applying these new proteomic advances, novel therapeutic and/or diagnostic protein targets will be discovered in the obesity/Type 2 diabetes area.

[1]  N. Anderson,et al.  Proteome and proteomics: New technologies, new concepts, and new words , 1998, Electrophoresis.

[2]  K. Ashman,et al.  Phosphoproteomics and cancer research , 2009, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

[3]  Frode S Berven,et al.  Developments in biobanking workflow standardization providing sample integrity and stability. , 2013, Journal of proteomics.

[4]  Phillip C. Wright,et al.  An insight into iTRAQ: where do we stand now? , 2012, Analytical and Bioanalytical Chemistry.

[5]  P. Budde,et al.  Peptidomics biomarker discovery in mouse models of obesity and type 2 diabetes. , 2005, Combinatorial chemistry & high throughput screening.

[6]  J. Yates,et al.  An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database , 1994, Journal of the American Society for Mass Spectrometry.

[7]  Scott A Gerber,et al.  Large-scale phosphorylation analysis of alpha-factor-arrested Saccharomyces cerevisiae. , 2007, Journal of proteome research.

[8]  S Kaspar,et al.  Recent progress in liquid chromatography-based separation and label-free quantitative plant proteomics. , 2011, Phytochemistry.

[9]  Melissa J. Morine,et al.  Perspective: a systems approach to diabetes research , 2013, Front. Genet..

[10]  R. Aebersold,et al.  Selected reaction monitoring–based proteomics: workflows, potential, pitfalls and future directions , 2012, Nature Methods.

[11]  J. Argente,et al.  El proteoma del tejido adiposo subcutáneo muestra heterogeneidad anatómica , 2013 .

[12]  F. Marincola,et al.  The international effort: building the bridge for Translational Medicine: Report of the 1st International Conference of Translational Medicine (ICTM) , 2012, Clinical and Translational Medicine.

[13]  P. James,et al.  Protein identification in the post-genome era: the rapid rise of proteomics , 1997, Quarterly Reviews of Biophysics.

[14]  J. Kopchick,et al.  Perspective: proteomic approach to detect biomarkers of human growth hormone. , 2009, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[15]  J. Carlis,et al.  Mass spectrometry-based proteomics: basic principles and emerging technologies and directions. , 2013, Advances in experimental medicine and biology.

[16]  Arvind M. Korwar,et al.  Proteomic study reveals downregulation of apolipoprotein A1 in plasma of poorly controlled diabetes: a pilot study. , 2013, Molecular medicine reports.

[17]  A. Masood,et al.  Mature adipocyte proteome reveals differentially altered protein abundances between lean, overweight and morbidly obese human subjects , 2015, Molecular and Cellular Endocrinology.

[18]  H. Tammen,et al.  Towards characterization of the human urinary peptidome. , 2005, Combinatorial chemistry & high throughput screening.

[19]  M. Larsen,et al.  SIMAC (Sequential Elution from IMAC), a Phosphoproteomics Strategy for the Rapid Separation of Monophosphorylated from Multiply Phosphorylated Peptides*S , 2008, Molecular & Cellular Proteomics.

[20]  E. Mariman,et al.  Hypoxia-mimetic effects in the secretome of human preadipocytes and adipocytes. , 2013, Biochimica et biophysica acta.

[21]  J. Argente,et al.  Effect of oral glucose administration on ghrelin levels in obese children. , 2004, European journal of endocrinology.

[22]  Matthias Mann,et al.  Analysis of High Accuracy, Quantitative Proteomics Data in the MaxQB Database , 2012, Molecular & Cellular Proteomics.

[23]  F. Pociot,et al.  TiSH--a robust and sensitive global phosphoproteomics strategy employing a combination of TiO2, SIMAC, and HILIC. , 2012, Journal of proteomics.

[24]  Martin R Larsen,et al.  Evaluation of the impact of some experimental procedures on different phosphopeptide enrichment techniques. , 2007, Rapid communications in mass spectrometry : RCM.

[25]  J. Kopchick,et al.  Analysis of mouse skin reveals proteins that are altered in a diet‐induced diabetic state: A new method for detection of type 2 diabetes , 2007, Proteomics.

[26]  Chi-Yu Lu,et al.  Proteomic Profiling for Peritoneal Dialysate: Differential Protein Expression in Diabetes Mellitus , 2013, BioMed research international.

[27]  A. Stensballe,et al.  Large-scale Analysis of in Vivo Phosphorylated Membrane Proteins by Immobilized Metal Ion Affinity Chromatography and Mass Spectrometry* , 2003, Molecular & Cellular Proteomics.

[28]  Charles DeLisi,et al.  Meetings that changed the world: Santa Fe 1986: Human genome baby-steps , 2008, Nature.

[29]  M. Caron,et al.  Cancer Immunomics Using Autoantibody Signatures for Biomarker Discovery* , 2007, Molecular & Cellular Proteomics.

[30]  W. Cho,et al.  Proteomics-based discovery of biomarkers for paediatric acute lymphoblastic leukaemia: challenges and opportunities , 2014, Journal of cellular and molecular medicine.

[31]  Hye Kyong Kweon,et al.  Selective zirconium dioxide-based enrichment of phosphorylated peptides for mass spectrometric analysis. , 2006, Analytical chemistry.

[32]  D. Hochstrasser,et al.  From Proteins to Proteomes: Large Scale Protein Identification by Two-Dimensional Electrophoresis and Arnino Acid Analysis , 1996, Bio/Technology.

[33]  K. Sikora,et al.  Serum Levels of C-Myc and C-Ras Oncogene Products in Normal Subjects and in Patients with Neoplastic and Non Neoplastic Conditions , 1986, The International journal of biological markers.

[34]  J. Buse,et al.  Salivary proteins associated with hyperglycemia in diabetes: a proteomic analysis. , 2013, Molecular bioSystems.

[35]  J. Argente,et al.  Insulin and growth hormone-releasing peptide-6 (GHRP-6) have differential beneficial effects on cell turnover in the pituitary, hypothalamus and cerebellum of streptozotocin (STZ)-induced diabetic rats , 2011, Molecular and Cellular Endocrinology.

[36]  Graham B. I. Scott,et al.  HUPO Plasma Proteome Project specimen collection and handling: Towards the standardization of parameters for plasma proteome samples , 2005, Proteomics.

[37]  L. Howells,et al.  Potential for proteomic approaches in determining efficacy biomarkers following administration of fish oils rich in omega-3 fatty acids: application in pancreatic cancers. , 2015, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[38]  Y. Iwadate Clinical proteomics in cancer research-promises and limitations of current two-dimensional gel electrophoresis. , 2008, Current medicinal chemistry.

[39]  J. Minden Comparative proteomics and difference gel electrophoresis. , 2007, BioTechniques.

[40]  S. Ravikumar,et al.  A proteomics approach to identify the differential protein level in cardiac muscle of diabetic rat. , 2014, Acta biochimica Polonica.

[41]  M. Mann,et al.  Dissection of the insulin signaling pathway via quantitative phosphoproteomics , 2008, Proceedings of the National Academy of Sciences.

[42]  Knut Reinert,et al.  Tools for Label-free Peptide Quantification , 2012, Molecular & Cellular Proteomics.

[43]  Akshay Bhat,et al.  Clinical proteomic biomarkers: relevant issues on study design & technical considerations in biomarker development , 2014, Clinical and Translational Medicine.

[44]  M. Mann,et al.  Quantitative Phosphoproteomics Applied to the Yeast Pheromone Signaling Pathway*S , 2005, Molecular & Cellular Proteomics.

[45]  M. Abu-Farha,et al.  Proteomics Analysis of Human Obesity Reveals the Epigenetic Factor HDAC4 as a Potential Target for Obesity , 2013, PloS one.

[46]  P. Budde,et al.  Prerequisites for peptidomic analysis of blood samples: II. Analysis of human plasma after oral glucose challenge -- a proof of concept. , 2005, Combinatorial chemistry & high throughput screening.

[47]  W. Cho,et al.  Application of oncoproteomics to aberrant signalling networks in changing the treatment paradigm in acute lymphoblastic leukaemia , 2014, Journal of cellular and molecular medicine.

[48]  H. Hwang,et al.  Proteomic analysis in ob/ob mice before and after hypoglycemic polysaccharide treatments. , 2009, Journal of microbiology and biotechnology.

[49]  P. Elliott,et al.  The UK Biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine. , 2008, International journal of epidemiology.

[50]  P. Roepstorff,et al.  Highly Selective Enrichment of Phosphorylated Peptides from Peptide Mixtures Using Titanium Dioxide Microcolumns* , 2005, Molecular & Cellular Proteomics.

[51]  Matthias Mann,et al.  In-depth Analysis of the Adipocyte Proteome by Mass Spectrometry and Bioinformatics*S , 2007, Molecular & Cellular Proteomics.

[52]  L. Zhang,et al.  Recent advances in micro-scale and nano-scale high-performance liquid-phase chromatography for proteome research , 2011, Analytical and bioanalytical chemistry.

[53]  Elena López,et al.  Relevant phosphoproteomic and mass spectrometry: approaches useful in clinical research , 2012, Clinical and Translational Medicine.

[54]  M. Mori,et al.  Recent Progress and Applications of Ion-exclusion/Ion-exchange Chromatography for Simultaneous Determination of Inorganic Anions and Cations , 2012, Analytical sciences : the international journal of the Japan Society for Analytical Chemistry.

[55]  M. Mann,et al.  Trypsin Cleaves Exclusively C-terminal to Arginine and Lysine Residues*S , 2004, Molecular & Cellular Proteomics.

[56]  Bhanu P. Jena,et al.  Journal of Cellular and Molecular Medicine , 2014, Journal of Cellular and Molecular Medicine.

[57]  L. Zhang,et al.  Recent advances on multidimensional liquid chromatography-mass spectrometry for proteomics: from qualitative to quantitative analysis--a review. , 2012, Analytica chimica acta.

[58]  Antonio Ferreira,et al.  Discovering and validating unknown phospho-sites from p38 and HuR protein kinases in vitro by Phosphoproteomic and Bioinformatic tools , 2011, Journal of Clinical Bioinformatics.

[59]  Gennifer E. Merrihew,et al.  Expediting the development of targeted SRM assays: using data from shotgun proteomics to automate method development. , 2009, Journal of proteome research.

[60]  A. Belenchia,et al.  Correcting vitamin D insufficiency improves insulin sensitivity in obese adolescents: a randomized controlled trial. , 2013, The American journal of clinical nutrition.

[61]  Y. Cordeiro,et al.  Ligand Binding and Hydration in Protein Misfolding: Insights from Studies of Prion and p53 Tumor Suppressor Proteins† , 2009, Accounts of chemical research.

[62]  Kai Pong Law,et al.  Recent advances in mass spectrometry: data independent analysis and hyper reaction monitoring , 2013, Expert review of proteomics.

[63]  Nan Wang,et al.  ProtQuant: a tool for the label-free quantification of MudPIT proteomics data , 2007, BMC Bioinformatics.

[64]  Jan-Jaap Wesselink,et al.  Technical phosphoproteomic and bioinformatic tools useful in cancer research , 2011, Journal of Clinical Bioinformatics.

[65]  J. Griffiths,et al.  Multiple Reaction Monitoring to Identify Sites of Protein Phosphorylation with High Sensitivity *S , 2005, Molecular & Cellular Proteomics.

[66]  M. Mann,et al.  Tyrosine Phosphoproteomics of Fibroblast Growth Factor Signaling , 2004, Journal of Biological Chemistry.

[67]  Yasset Perez-Riverol,et al.  Open source libraries and frameworks for mass spectrometry based proteomics: A developer's perspective , 2014, Biochimica et biophysica acta.

[68]  Shao-En Ong The expanding field of SILAC , 2012, Analytical and Bioanalytical Chemistry.

[69]  D. Daly,et al.  ELISA microarray technology as a high-throughput system for cancer biomarker validation , 2006, Expert review of proteomics.

[70]  T. Horvath,et al.  Uncovering novel roles of nonneuronal cells in body weight homeostasis and obesity. , 2013, Endocrinology.

[71]  Hongyu Zhao,et al.  Protein quantitation using iTRAQ: Review on the sources of variations and analysis of nonrandom missingness. , 2012, Statistics and its interface.

[72]  F. Tinahones,et al.  Proteomic analysis of visceral adipose tissue in pre-obese patients with type 2 diabetes , 2013, Molecular and Cellular Endocrinology.

[73]  R. Kineman,et al.  Adiponectin in mice with altered GH action: links to insulin sensitivity and longevity? , 2013, The Journal of endocrinology.

[74]  H. Christofk,et al.  A label‐free quantification method by MS/MS TIC compared to SILAC and spectral counting in a proteomics screen , 2008, Proteomics.

[75]  M. Mann,et al.  Decoding signalling networks by mass spectrometry-based proteomics , 2010, Nature Reviews Molecular Cell Biology.

[76]  F. Tinahones,et al.  Proteomic analysis of adipose tissue: informing diabetes research , 2014, Expert review of proteomics.

[77]  K. Kinzler,et al.  Mutant proteins as cancer-specific biomarkers , 2011, Proceedings of the National Academy of Sciences.

[78]  F. Prodam,et al.  Pediatric Obesity and Vitamin D Deficiency: A Proteomic Approach Identifies Multimeric Adiponectin as a Key Link between These Conditions , 2014, PloS one.

[79]  Matthias Mann,et al.  Mass spectrometry–based proteomics in cell biology , 2010, The Journal of cell biology.

[80]  R. Cooks,et al.  Multiple reaction monitoring in mass spectrometry/mass spectrometry for direct analysis of complex mixtures , 1978 .

[81]  R. Aebersold,et al.  Selected reaction monitoring for quantitative proteomics: a tutorial , 2008, Molecular systems biology.

[82]  P. Bingley,et al.  Validation of Autoantibody Assays in Type 1 Diabetes: Workshop Programme , 2004, Autoimmunity.

[83]  Jens M. Rick,et al.  Quantitative mass spectrometry in proteomics: a critical review , 2007, Analytical and bioanalytical chemistry.

[84]  Mei Yin,et al.  Investigation of the Protective Effects of Phlorizin on Diabetic Cardiomyopathy in db/db Mice by Quantitative Proteomics , 2013, Journal of diabetes research.

[85]  R. Aebersold,et al.  Mass spectrometry-based proteomics , 2003, Nature.

[86]  N. Nagaraj,et al.  Proteomics: a strategy to understand the novel targets in protein misfolding and cancer therapy , 2010, Expert review of proteomics.

[87]  J. Kopchick,et al.  Perspective: Proteomics-See "Spots" Run. , 2002, Endocrinology.

[88]  M. Latterich,et al.  Clinical proteomics and OMICS clues useful in translational medicine research , 2012, Proteome Science.

[89]  A. Masood,et al.  Proteomic analysis of mature adipo cytes from obese patients in relation to aging , 2013, Experimental Gerontology.

[90]  Lukas N. Mueller,et al.  An assessment of software solutions for the analysis of mass spectrometry based quantitative proteomics data. , 2008, Journal of proteome research.

[91]  W. Blackstock,et al.  Proteomics: quantitative and physical mapping of cellular proteins. , 1999, Trends in biotechnology.

[92]  Derek J. Bailey,et al.  Parallel Reaction Monitoring for High Resolution and High Mass Accuracy Quantitative, Targeted Proteomics* , 2012, Molecular & Cellular Proteomics.

[93]  J. Argente,et al.  Proteomic analysis allows for early detection of potential markers of metabolic impairment in very young obese children , 2014, International Journal of Pediatric Endocrinology.

[94]  Stephen W Holman,et al.  The use of selected reaction monitoring in quantitative proteomics. , 2012, Bioanalysis.

[95]  H. Jörnvall,et al.  The impact of pre-analytical conditions on the serum proteome: heat-stabilization versus nitrogen storage , 2013, Archives of physiology and biochemistry.

[96]  A. Bartke,et al.  The effect of calorie restriction on insulin signaling in skeletal muscle and adipose tissue of Ames dwarf mice , 2014, Aging.

[97]  Frank Vitzthum,et al.  Effects of preanalytical variables on peptide and protein measurements in human serum and plasma: implications for clinical proteomics , 2006, Expert review of proteomics.

[98]  J. Argente,et al.  Adipokines in childhood obesity. , 2013, Vitamins and hormones.

[99]  J. Kopchick,et al.  Plasma Protein Biomarkers Correlated with the Development of Diet-Induced Type 2 Diabetes in Mice , 2010, Clinical Proteomics.

[100]  M. Crawford The Human Genome Project. , 1990, Human biology.

[101]  M. Ueffing,et al.  Apoe, Mbl2, and Psp plasma protein levels correlate with diabetic phenotype in NZO mice--an optimized rapid workflow for SRM-based quantification. , 2013, Journal of proteome research.

[102]  N. Bykova,et al.  Novel regulatory roles of omega-3 fatty acids in metabolic pathways: a proteomics approach , 2014, Nutrition & Metabolism.

[103]  E. Hoffmann Tandem mass spectrometry: A primer , 1996 .

[104]  Henning Hermjakob,et al.  Meeting New Challenges: The 2014 HUPO‐PSI/COSMOS Workshop , 2014, Proteomics.

[105]  M. Kasuga,et al.  Differential proteome analysis of serum proteins associated with the development of type 2 diabetes mellitus in the KK-A(y) mouse model using the iTRAQ technique. , 2013, Journal of proteomics.

[106]  Etienne Waelkens,et al.  High glucose induces dysfunction in insulin secretory cells by different pathways: a proteomic approach. , 2010, Journal of proteome research.

[107]  J. M. Ordovás Muñoz Predictors of obesity: the "power" of the omics. , 2013, Nutricion hospitalaria.

[108]  J. Kopchick,et al.  Novel serum protein biomarkers indicative of growth hormone doping in healthy human subjects , 2011, Proteomics.

[109]  Samuel H. Payne,et al.  A Multidimensional Chromatography Technology for In-depth Phosphoproteome Analysis*S , 2008, Molecular & Cellular Proteomics.

[110]  D. Crimmins Applications of strong cation-exchange (SCX)-HPLC in synthetic peptide analysis. , 1994, Methods in molecular biology.